MEVIS MEDICAL SOLUTIONS AG/ DE000A0LBFE4 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 43.68 mill.EUR | 0.00% | 9.61 |
Assets
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .3000 | .2000 | .2000 | .2000 | .1000 | ||||||
Intangible Assets | 11.7000 | 11.1000 | .0200 | .0100 | 0.0000 | ||||||
Long-Term Investments | 2 | 18.3000 | 16.5000 | 16.5000 | 16.5000 | ||||||
Fixed Assets | 15.7000 | 31.3000 | 16.5000 | 16.7000 | 16.7000 | ||||||
Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | 3.4000 | 3.3000 | 2.5000 | 2.7000 | 2.3000 | ||||||
Cash and Cash Equivalents | 29.7000 | 3.5000 | 2.6000 | 4 | 7.6000 | ||||||
Current Assets | 33.4000 | 7.2000 | 7 | 11 | 10.8000 | ||||||
Total Assets | 49.1000 | 38.4000 | 23.9000 | 27.8000 | 27.5000 |
Liabilities
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .3000 | .3000 | - | - | - | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 11.4000 | 2.7000 | - | - | - | ||||||
Provisions | 1.6000 | 1.5000 | - | - | - | ||||||
Liabilities | 16.6000 | 6.4000 | 6.1000 | 10 | 9.7000 | ||||||
Share Capital | 1.8200 | 1.8200 | 1.8200 | 1.8200 | 1.8200 | ||||||
Total Equity | 32.5000 | 32.1000 | 17.8000 | 17.8000 | 17.8000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 49.1000 | 38.4000 | 23.9000 | 27.8000 | 27.5000 |
Income Statement
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 18.5000 | 16.8000 | 18.1000 | 17.1000 | 16.2000 | ||||||
Depreciation (total) | 1.2000 | .9000 | .3000 | .2000 | .1000 | ||||||
Operating Result | 8 | 6.7000 | 7.5000 | 5.5000 | 4.5000 | ||||||
Interest Income | .1900 | .1800 | .1900 | .1900 | .1900 | ||||||
Income Before Taxes | 7.2000 | 7.3000 | 8.1000 | 5.7000 | 4.6000 | ||||||
Income Taxes | 1.5000 | .0900 | .0900 | .0900 | .0900 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 5.6000 | 7.2000 | 8.1000 | 5.7000 | 4.5000 |
Per Share
Cash Flow
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 7.3000 | 5.5000 | 6.5000 | 2.9000 | 9.1000 | ||||||
Cash Flow from Investing Activities | -.2000 | -22.4000 | -5.9000 | .2000 | .1000 | ||||||
Cash Flow from Financing | 0.0000 | -9.4000 | -1.6000 | -1.6000 | -5.7000 | ||||||
Decrease / Increase in Cash | 7.1000 | -26.3000 | -1 | 1.5000 | 3.5000 | ||||||
Employees | 93 | 94 | 102 | 108 | 104 |